Pylobactell Euroopan unioni - suomi - EMA (European Medicines Agency)

pylobactell

torbet laboratories ireland limited - urea (13c) - breath tests; helicobacter infections - diagnostiset aineet - tämä lääkevalmiste on tarkoitettu vain diagnostiseen käyttöön. in vivo-diagnosointiin maha-pohjukaissuolen helicobacter pylori - (h. pylori) - infektio.

LOBAC tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

lobac tabletti

sanofi-synthelabo ab - chlormezanonum,paracetamolum - tabletti - kloorimetsanoni, yhdistelmävalmisteet

Balance 1.5 % Glukoosi, 1.25 Mmol/L Kalsium peritoneaalidialyysineste Suomi - suomi - Fimea (Suomen lääkevirasto)

balance 1.5 % glukoosi, 1.25 mmol/l kalsium peritoneaalidialyysineste

fresenius medical care deutschland gmbh - glucose monohydrate, sodium lactate, sodium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate - peritoneaalidialyysineste - hypertoniset liuokset

Balance 1.5 % Glukoosi 1.75 Mmol/L Kalsium peritoneaalidialyysineste Suomi - suomi - Fimea (Suomen lääkevirasto)

balance 1.5 % glukoosi 1.75 mmol/l kalsium peritoneaalidialyysineste

fresenius medical care deutschland gmbh - glucose monohydrate, sodium lactate, sodium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate - peritoneaalidialyysineste - hypertoniset liuokset

Balance 4.25 % Glukoosi 1.75 Mmol/L Kalsium peritoneaalidialyysineste Suomi - suomi - Fimea (Suomen lääkevirasto)

balance 4.25 % glukoosi 1.75 mmol/l kalsium peritoneaalidialyysineste

fresenius medical care deutschland gmbh - glucose monohydrate, sodium lactate, sodium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate - peritoneaalidialyysineste - hypertoniset liuokset

Balance 2.3 % Glukoosi 1.75 Mmol/L Kalsium peritoneaalidialyysineste Suomi - suomi - Fimea (Suomen lääkevirasto)

balance 2.3 % glukoosi 1.75 mmol/l kalsium peritoneaalidialyysineste

fresenius medical care deutschland gmbh - glucose monohydrate, sodium lactate, sodium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate - peritoneaalidialyysineste - hypertoniset liuokset

Balance 4.25 % Glukoosi, 1.25 Mmol/L Kalsium peritoneaalidialyysineste Suomi - suomi - Fimea (Suomen lääkevirasto)

balance 4.25 % glukoosi, 1.25 mmol/l kalsium peritoneaalidialyysineste

fresenius medical care deutschland gmbh - glucose monohydrate, sodium lactate, sodium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate - peritoneaalidialyysineste - hypertoniset liuokset

Balance 2.3 % Glukoosi, 1.25 Mmol/L Kalsium peritoneaalidialyysineste Suomi - suomi - Fimea (Suomen lääkevirasto)

balance 2.3 % glukoosi, 1.25 mmol/l kalsium peritoneaalidialyysineste

fresenius medical care deutschland gmbh - glucose monohydrate, sodium lactate, sodium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate - peritoneaalidialyysineste - hypertoniset liuokset

Comirnaty Euroopan unioni - suomi - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - rokotteet - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. käyttö tämä rokote tulee virallisten suositusten mukaisesti.

Alfuzosin Hydrochlorid Ratiopharm 10 mg depottabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

alfuzosin hydrochlorid ratiopharm 10 mg depottabletti

ratiopharm gmbh - alfuzosin hydrochloride - depottabletti - 10 mg - alfutsosiini